New partially bullshit which Big Pharma's throwing at us to see if it will stick:
Pfizer Paxlovid and Merk's Molnupiravir; Though the panel backed the pill, the meeting was contentious. Several doctors expressed concerns about potential side effects from the drug as well as its possible impact on the ***future evolution of the virus***.
Molnupiravir** prompts the virus to mutate **and produce errors** that inhibit its ability to replicate, Merck said.
“Even if the probability is very low, 1 in 10,000 or 100,000, that ***this drug would *induce* an 'escape mutant', from which the vaccines we have do not cover --- that could be ***catastrophic*** for the whole world actually***, ” Dr. James Hildreth, CEO of Meharry Medical College in Nashville, Tennessee, told the panel the FDA panel in November.
Pfizer Paxlovid and Merk's Molnupiravir; Though the panel backed the pill, the meeting was contentious. Several doctors expressed concerns about potential side effects from the drug as well as its possible impact on the ***future evolution of the virus***.
Molnupiravir** prompts the virus to mutate **and produce errors** that inhibit its ability to replicate, Merck said.
“Even if the probability is very low, 1 in 10,000 or 100,000, that ***this drug would *induce* an 'escape mutant', from which the vaccines we have do not cover --- that could be ***catastrophic*** for the whole world actually***, ” Dr. James Hildreth, CEO of Meharry Medical College in Nashville, Tennessee, told the panel the FDA panel in November.
New partially bullshit which Big Pharma's throwing at us to see if it will stick:
Pfizer Paxlovid and Merk's Molnupiravir; Though the panel backed the pill, the meeting was contentious. Several doctors expressed concerns about potential side effects from the drug as well as its possible impact on the ***future evolution of the virus***.
Molnupiravir** prompts the virus to mutate **and produce errors** that inhibit its ability to replicate, Merck said.
“Even if the probability is very low, 1 in 10,000 or 100,000, that ***this drug would *induce* an 'escape mutant', from which the vaccines we have do not cover --- that could be ***catastrophic*** for the whole world actually***, ” Dr. James Hildreth, CEO of Meharry Medical College in Nashville, Tennessee, told the panel the FDA panel in November.
0 Comentários
0 Compartilhamentos
734 Visualizações